share_log

BRIEF-TG Therapeutics Announces Publication Of Results From The UNITY-NHL Phase 2b Trial

路透社 ·  Mar 9, 2021 21:02
March 9 (Reuters) - TG Therapeutics Inc :
   * TG THERAPEUTICS ANNOUNCES PUBLICATION OF RESULTS FROM THE UNITY-NHL PHASE 2B TRIAL EVALUATING UMBRALISIB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA IN THE JOURNAL OF CLINICAL ONCOLOGY

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment